Timing of infections in patients with primary immunodeficiencies treated with intravenous immunoglobulin (IVIg)

PURPOSE: Patients with common variable immune deficiency and X-linked agammaglobulinemia are unable to produce their own antibodies thus leading to a higher incidence of recurrent infections, particularly those involving the sinuses and lungs. Treatment with intravenous immunoglobulin therapy aims t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gill, Parwinder K., Betschel, Stephen D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088426/
https://www.ncbi.nlm.nih.gov/pubmed/30123298
http://dx.doi.org/10.1186/s13223-018-0247-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088426/
https://www.ncbi.nlm.nih.gov/pubmed/30123298
http://dx.doi.org/10.1186/s13223-018-0247-8

Ejemplares similares